US Edition
News about Chengdu
Stay current with all the latest and breaking news about Chengdu, compare headlines and perspectives between news sources on stories happening today. In total, 381 stories have been published about Chengdu which Ground News has aggregated in the past 3 months.
Weather
77°F
77°FFriday
65° | 70°F
65° | 70°FSaturday
63° | 72°F
63° | 72°FSunday63° | 69°F
63° | 69°FMonday59° | 62°F
59° | 62°FTuesday56° | 59°F
56° | 59°FWednesday56° | 56°F
56° | 56°FLocal News Publishers
Suggest a source
Looking for a source we don't already have? Suggest one here.Top Chengdu News
![C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001](/_next/image?url=%2F_next%2Fstatic%2Fmedia%2Fgeneric_3_half.64d0bbed.webp&w=1440&q=75)
Chengdu · ChengduCHENGDU, China, Oct. 11, 2025 /PRNewswire/ -- C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the National Medical Products Administration (NMPA) for the clinical trial application of [177Lu]-BL-ARC001 Injection, the company's first…See the Story
C-Ray Therapeutics (Chengdu) Co., Ltd Congratulates Partner Biokin Pharmaceutical on NMPA IND Approval of First Proprietary ARC Drug [177Lu]-BL-ARC001
72% Center coverage: 7 sources
Chengdu · ChengduCHENGDU, China, Oct. 13, 2025 /PRNewswire/ -- iRegene Therapeutics Co., Ltd. ("iRegene" or the "Company") is recognized as a biotechnology company pioneering chemically induced allogeneic cell therapy. iRegene's lead product, NouvNeu001, is the 1st iPSC therapy to receive IND approval…See the Story
iRegene Therapeutics announced promising NouvNeu001 Phase I clinical data
67% Center coverage: 3 sources
Chengdu · ChengduCHENGDU, CN / ACCESS Newswire / October 14, 2025 / WeTouch Technology Inc. (Nasdaq:WETH) ("WeTouch" or the "Company"), a leading provider of premium touch display solutions, today announced that it has received official notification from The Nasdaq Stock Market LLC…See the Story
WeTouch Announces Regaining Compliance with Periodic Reporting Requirements and Nasdaq Listing Rule 5250(c)(1)
Coverage: 2 sources
